Physician profile
Anne E Bush
NPI 1770511792
$425.27
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $183 · 2021: $14.14 · 2022: $99.74 · 2023: $15.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $83.22 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.65 | 2020-2022 | |
| Qol Medical, LLC | $52.85 | 2019-2020 | |
| Gilead Sciences, INC. | $48.80 | 2020-2022 | |
| Intercept Pharmaceuticals, INC. | $42.41 | 2020-2022 | |
| Braintree Laboratories, INC. | $27.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.88 | 2020 | |
| Merck Sharp & Dohme LLC | $18.57 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.02 | 2020 | |
| Capsovision, INC. | $15.75 | 2023 | Capsocam Plus |
| Ethicon US, LLC | $13.58 | 2020 | |
| Redhill Biopharma INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.